2:57 PM
 | 
Nov 30, 2018
 |  BioCentury  |  Finance

Global Dimensions

A look at 6 Dimensions’ global investment strategy

6 Dimensions Capital has invested in at least nine U.S. biotechs this year out of its inaugural U.S. dollar fund, and the pace is expected to continue.

Those investments have caught the eye of the United States Trade Representative, which last week named 6 Dimensions as one of many “Chinese VCs” accessing U.S. technology through its investments (see “Chinese Foothold in U.S. Biotech is Growing, USTR Report Finds”).

But 6 Dimensions’ Leon Chen said the VC does not characterize itself as Chinese, but rather as a global healthcare firm. It has offices in Shanghai, Hong Kong, Boston and San Francisco.

“We play an essential...

Read the full 501 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >